SCHEMBL2449178

SCHEMBL2449178

O=C(Nc1noc2cccc(OCC(F)(F)F)c12)Oc1ccc2ccccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 2/20 0.38
XBP1 P17861 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
IDO1 P14902 1/20 0.38
SGMS2 Q8NHU3 2/20 0.37
HIF1A Q16665 1/20 0.37
SGMS1 Q86VZ5 1/20 0.37
UGCG Q16739 1/20 0.37
LMNA P02545 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
S1PR2 O95136 1/20 0.36
S1PR4 O95977 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2440639 0.83 SGMS2 (0.38) KDM4EMAPTNPC1RAB9AIDO1
SCHEMBL2446170 0.78 HIF1A (0.58) MEN1KMT2AKDM4EMAPTSMN1; SMN2
Cyclopropane SCHEMBL2441865 0.77 KCNA5 (0.39) MEN1KMT2AMAPTSMN1; SMN2GAA
Cyclohexane SCHEMBL2442882 0.77 KCNA5 (0.39) MEN1KMT2AMAPTSMN1; SMN2GAA
SCHEMBL2437975 0.77 KDM4E (0.43) MEN1KMT2AKDM4EMAPTSMN1; SMN2
SCHEMBL2442656 0.76 KCNA5 (0.40) MEN1KMT2ASMN1; SMN2SGMS2SGMS1
SCHEMBL2443219 0.76 EPHX2 (0.54) KDM4EMAPTSMN1; SMN2IDO1HIF1A
SCHEMBL2437982 0.75 S1PR1 (0.49) MEN1KMT2AMAPTSMN1; SMN2GAA
SCHEMBL2441287 0.75 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9ATDP1SGMS2
SCHEMBL2440764 0.74 TP53 (0.44) MAPTSMN1; SMN2SGMS2UGCGLCLAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP claimed
EP-1893589-A1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS Grünenthal GmbH (DE) 2008-03-05 EP claimed
WO-2006131296-A1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS Grünenthal GmbH (DE) 2006-12-14 WO claimed
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP disclosed
EP-1893589-A1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS Grünenthal GmbH (DE) 2008-03-05 EP disclosed
WO-2006131296-A1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS Grünenthal GmbH (DE) 2006-12-14 WO disclosed